Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

Prioritising treatment among people who inject drugs in order to eliminate hepatitis C: addressing reluctance with sound economic analyses.

Hutin YJ, Wiktor SZ.

Gut. 2016 Aug 26. pii: gutjnl-2016-312636. doi: 10.1136/gutjnl-2016-312636. [Epub ahead of print] No abstract available.

PMID:
27566128
2.

The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts.

Wiktor SZ, Hutin YJ.

Lancet. 2016 Sep 10;388(10049):1030-1. doi: 10.1016/S0140-6736(16)31018-2. No abstract available.

PMID:
27394646
3.

Global policy and access to new hepatitis C therapies for people who inject drugs.

Doyle JS, Aspinall EJ, Hutchinson SJ, Quinn B, Gore C, Wiktor SZ, Hellard ME.

Int J Drug Policy. 2015 Nov;26(11):1064-71. doi: 10.1016/j.drugpo.2015.05.008. Review.

PMID:
26118794
4.

Deciding who should be treated for hepatitis C infection in a rapidly changing therapeutic landscape.

Wiktor SZ.

Hepatology. 2015 Jul;62(1):13-5. doi: 10.1002/hep.27810. No abstract available.

PMID:
25820452
5.

Where next for hepatitis B and C surveillance?

Wiktor SZ.

J Viral Hepat. 2015 Jul;22(7):571-3. doi: 10.1111/jvh.12400. Review.

PMID:
25754464
6.

World health organization approaches to evaluating the potential use and quality of hepatitis e vaccine.

Harmanci H, Duclos P, Rodriguez Hernandez CA, Meek A, Balakrishnan MR, Kumar Arora N, Wiktor SZ.

Open Forum Infect Dis. 2014 Dec 2;1(3):ofu099. doi: 10.1093/ofid/ofu099. No abstract available.

7.

Targeted hepatitis C antibody testing interventions: a systematic review and meta-analysis.

Aspinall EJ, Doyle JS, Corson S, Hellard ME, Hunt D, Goldberg D, Nguyen T, Falck-Ytter Y, Morgan RL, Smith B, Stoove M, Wiktor SZ, Hutchinson S.

Eur J Epidemiol. 2015 Feb;30(2):115-29. doi: 10.1007/s10654-014-9958-4. Review.

8.

A new method for imputing country-level estimates of hepatitis A virus endemicity levels in the Eastern Mediterranean region.

Itani T, Jacobsen KH, Nguyen T, Wiktor SZ.

Vaccine. 2014 Oct 21;32(46):6067-74. doi: 10.1016/j.vaccine.2014.09.006. Review.

PMID:
25236586
9.

Evaluation of using routine infant immunization visits to identify and follow-up HIV-exposed infants and their mothers in Tanzania.

Goodson JL, Finkbeiner T, Davis NL, Lyimo D, Rwebembera A, Swartzendruber AL, Wallace AS, Kimambo S, Kimario CJ, Wiktor SZ, Luman ET.

J Acquir Immune Defic Syndr. 2013 May 1;63(1):e9-e15. doi: 10.1097/QAI.0b013e31828a3e3f.

PMID:
23406977
10.

Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis.

Becquet R, Marston M, Dabis F, Moulton LH, Gray G, Coovadia HM, Essex M, Ekouevi DK, Jackson D, Coutsoudis A, Kilewo C, Leroy V, Wiktor SZ, Nduati R, Msellati P, Zaba B, Ghys PD, Newell ML; UNAIDS Child Survival Group..

PLoS One. 2012;7(2):e28510. doi: 10.1371/journal.pone.0028510.

11.

Cost-effectiveness of tuberculosis diagnostic strategies to reduce early mortality among persons with advanced HIV infection initiating antiretroviral therapy.

Abimbola TO, Marston BJ, Date AA, Blandford JM, Sangrujee N, Wiktor SZ.

J Acquir Immune Defic Syndr. 2012 May 1;60(1):e1-7. doi: 10.1097/QAI.0b013e318246538f.

PMID:
22240465
12.

Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control study.

Adjorlolo-Johnson G, Unger ER, Boni-Ouattara E, Touré-Coulibaly K, Maurice C, Vernon SD, Sissoko M, Greenberg AE, Wiktor SZ, Chorba TL.

BMC Infect Dis. 2010 Aug 17;10:242. doi: 10.1186/1471-2334-10-242.

13.

Faithfulness to partners: a means to prevent HIV infection, a source of HIV infection risks, or both? A qualitative study of women's experiences in Abidjan, Côte d'Ivoire.

Painter TM, Diaby KL, Matia DM, Lin LS, Sibailly TS, Kouassi MK, Ekpini ER, Roels TH, Wiktor SZ.

Afr J AIDS Res. 2007 Apr;6(1):25-31. doi: 10.2989/16085900709490396.

PMID:
25875342
14.

Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries.

McDougal JS, Pilcher CD, Parekh BS, Gershy-Damet G, Branson BM, Marsh K, Wiktor SZ.

AIDS. 2005 May;19 Suppl 2:S25-30. Review.

PMID:
15930838
15.

Sociodemographic factors associated with participation by HIV-1-positive pregnant women in an intervention to prevent mother-to-child transmission of HIV in Cote d'Ivoire.

Painter TM, Diaby KL, Matia DM, Lin LS, Sibailly TS, Kouassims MK, Ekpini ER, Roels TH, Wiktor SZ.

Int J STD AIDS. 2005 Mar;16(3):237-42.

PMID:
15829025
16.

Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire.

Kalou M, Sassan-Morokro M, Abouya L, Bile C, Maurice C, Maran M, Tossou O, Roels T, Greenberg AE, Wiktor SZ, Nkengasong JN.

J Med Virol. 2005 Feb;75(2):202-8.

PMID:
15602734
17.
18.

Effect of an HIV counseling and testing program on AIDS-related knowledge and practices in tuberculosis clinics in Abidjan, Côte d'Ivoire.

Wiktor SZ, Abouya L, Angoran H, McFarland J, Sassan-Morokro M, Tossou O, Coulibaly D, Coulibaly IM, Greenberg AE.

Int J Tuberc Lung Dis. 2004 Apr;8(4):445-50.

PMID:
15141737
19.

HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1.

Pieniazek D, Rayfield M, Hu DJ, Nkengasong JN, Soriano V, Heneine W, Zeh C, Agwale SM, Wambebe C, Odama L, Wiktor SZ.

AIDS. 2004 Feb 20;18(3):495-502.

PMID:
15090802
20.

Differences in HIV-2 plasma viral load and immune activation in HIV-1 and HIV-2 dually infected persons and those infected with HIV-2 only in Abidjan, Côte D'Ivoire.

Koblavi-Dème S, Kestens L, Hanson D, Otten RA, Borget MY, Bilé C, Wiktor SZ, Roels TH, Chorba T, Nkengasong JN.

AIDS. 2004 Feb 20;18(3):413-9.

PMID:
15090792
Items per page

Supplemental Content

Loading ...
Support Center